Keene & Associates »

Pfizer shares owned by Keene & Associates

Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Keene & Associates from 13F filings

Historical chart of Keene & Associates investment in Pfizer

Tip: Access up to 7 years of quarterly data

All positions including Pfizer held by Keene & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pfizer by Keene & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 112k 27.75
2023-12-31 $1.8M 64k 28.79
2023-09-30 $2.3M 68k 33.17
2023-06-30 $2.4M 65k 36.68
2023-03-31 $2.6M 64k 40.80
2022-12-31 $3.3M 64k 51.24
2022-09-30 $2.7M 62k 43.77
2022-06-30 $3.4M 65k 52.43
2022-03-31 $3.4M 65k 51.77
2021-12-31 $3.9M 66k 59.04